Related Experiment Video
Updated: Nov 6, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Provider and Practice Experience Integrating the Dose-HPV Intervention into Clinical Practice
Mari-Lynn Drainoni1, Dea Biancarelli, Emily Jansen
1Dr. Drainoni: Research Professor, Boston University Schools of Medicine and Public Health, Boston, MA; Codirector, Evans Center for Implementation and Improvement Sciences, Boston, MA. Ms. Biancarelli: Consultant, Accenture, Boston, MA. Ms. Jansen: Senior Program Manager, Boston University School of Medicine, Boston, MA. Dr. Bernstein: Emeritus Professor, Boston University School of Public Health; Professor of Emergency Medicine, Boston University School of Medicine, Boston, MA. Dr. Joseph: Clinical Associate Professor of Adolescent Medicine and Pediatrics, Boston University School of Medicine, Boston, MA. Ms. Eun: PhD Student, Department of Sociology, Stanford University, Boston, MA. Dr. Fenton: Postdoctoral Fellow, Center for Outcomes Research & Evaluation, Maine Medical Center Research Institute, Boston, MA. Dr. Clark: Professor, Boston University School of Public Health, Boston, MA. Dr. Hanchate: Associate Professor, Boston University Schools of Medicine and Public Health; Health Economist, VA Boston Healthcare System, Boston, MA. Mr. Legler: Senior Healthcare Statistician, Boston VA Healthcare System, Boston, MA. Dr. Schuch: Chief Information Officer, Pediatrician at South Boston Community Health Center, Boston, MA. Dr. Leschly : Assistant Professor, Boston University School of Medicine; Medical Director, East Boston Neighborhood Health Center, Boston, MA. Dr. Perkins: Associate Professor, Boston University School of Medicine, Boston, MA.
Successful implementation of the Development of Systems and Education for HPV Vaccination (DOSE HPV) intervention relied on evidence-based education, data feedback, leadership support, and collaboration. Workflow, communication, and competing priorities were identified as key barriers to improving human papillomavirus (HPV) vaccination rates.
Area of Science:
- Public Health
- Health Services Research
- Vaccination Science
Background:
- Few studies have rigorously evaluated the success factors for interventions aimed at increasing human papillomavirus (HPV) vaccination rates.
- The Development of Systems and Education for HPV Vaccination (DOSE HPV) intervention was designed to improve HPV vaccination coverage.
Purpose of the Study:
- To evaluate the implementation of the DOSE HPV performance improvement intervention.
- To identify factors contributing to the successful implementation and barriers encountered.
Main Methods:
- Qualitative interviews were conducted with primary care providers (PCPs), nurses, and leaders from pediatric and family medicine practices post-intervention.
- Interviews were professionally transcribed and analyzed using inductive coding and the Promoting Action on Research implementation in Health Services (PARiHS) model.
Main Results:
- Participants identified five success factors: evidence-based education, personalized data feedback, clinical leadership support, collaborative facilitation, and repeated intervention contacts.
- Identified barriers included workflow standardization issues, low pediatric volume, competing priorities, ineffective nurse involvement, and poor communication.
Conclusions:
- Effective implementation of HPV vaccination interventions like DOSE HPV requires more than just evidence-based design; it necessitates attention to collaborative approaches, data utilization, and sustained engagement.
- Addressing workflow, communication, and competing priorities is crucial for overcoming implementation barriers and ensuring the sustainability of interventions to improve HPV vaccination rates.
More Related Videos
Related Concept Videos
Nursing Implementation
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Dose-Response Relationship: Potency and Efficacy
Dose-Response Relationship: Overview
PPE Use in Healthcare Settings I: Donning
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

